Tradimed Phyto 3
Natural health product licensed in Canada
- Licence holder
- Les laboratoires Nicar inc.
- NPN or DIN-HM
- 80019095
- Status
- Inactive licence
- Licence date
- 31 May 2010
- Revision date
- 26 August 2010
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacea pallida Source : Racine | 500 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 5 years ; maximum: 9 years | 1 Capsule | 1 Tous les jours |
| Adolescentes | minimum: 15 years | 2 Capsule | 3 Tous les jours |
| Adolescentes | minimum: 10 years ; maximum: 14 years | 1 Capsule | 3 Tous les jours |
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Utilisée traditionellement en phytothérapie pour aider à soulager les symptômes du rhume. Thérapie de soutien pour traiter les infections des voies respiratoires supérieures (e.g. le rhume).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptôms persistent ou s'aggravent. Consulter un praticien de soins de santé avant d'en faire l'usage si vous prenez des immunosuppresseurs ou si vous souffrez d'une maladie auto-immune ou d'une maladie systémique progressive telle que la tuberculose, la leucose, la collagénose, la sclérose en plaque, le sida et/ou une infection au VIH.
Source
Official Health Canada record, licence 80019095
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging